Literature DB >> 4598691

BCG and cancer.

R C Bast, B Zbar, T Borsos, H J Rapp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4598691     DOI: 10.1056/NEJM197406272902605

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Cationic liposomes containing mycobacterial lipids: a new powerful Th1 adjuvant system.

Authors:  Ida Rosenkrands; Else Marie Agger; Anja W Olsen; Karen S Korsholm; Claire Swetman Andersen; Klaus T Jensen; Peter Andersen
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Melanoma of the head and neck.

Authors:  M N Harris; D F Roses; A T Culliford; S L Gumport
Journal:  Ann Surg       Date:  1975-07       Impact factor: 12.969

3.  The granulomatous inflammatory response. A review.

Authors:  D O Adams
Journal:  Am J Pathol       Date:  1976-07       Impact factor: 4.307

4.  Arthritis associated with adjuvant mycobacterial treatment for carcinoma of the bladder.

Authors:  R A Hughes; S A Allard; R N Maini
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

5.  Immunosuppressive activity of BCG: effects of adjuvant disease, lymphocyte subpopulations, and homing of thoracic duct cells in rats.

Authors:  R I Sutherland; M A Spadaro-Antonelli; V J Lawrence; F Quagliata
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

Review 6.  The role of immunotherapy in the management of patients with malignant melanoma.

Authors:  J E Goodnight; D L Morton
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

7.  Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; A M van der Wal; N G Orie
Journal:  Thorax       Date:  1978-08       Impact factor: 9.139

8.  Calpain-mediated processing of p53-associated parkin-like cytoplasmic protein (PARC) affects chemosensitivity of human ovarian cancer cells by promoting p53 subcellular trafficking.

Authors:  Michael G Woo; Kai Xue; Jiayin Liu; Heidi McBride; Benjamin K Tsang
Journal:  J Biol Chem       Date:  2011-11-23       Impact factor: 5.157

9.  Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.

Authors:  I T Magrath; J L Ziegler
Journal:  Br Med J       Date:  1976-03-13

10.  BCG and cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.